Cirrhotic patients with hereditary hemochromatosis (HHC) have an increased risk of primary liver cancer (PLC). The purpose of this study was to determine the prevalence of primary liver cancer in patients with HHC undergoing orthotopic liver transplantation (OLT). Five liver transplant centers were
Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesis
β Scribed by Darrell H.G. Crawford; Linda M. Fletcher; Stefan G. Hubscher; Katherine A. Stuart; Edward Gane; Peter W. Angus; Gary P. Jeffrey; Geoffrey W. McCaughan; Paul Kerlin; Lawrie W. Powell; Elwyn E. Elias
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 146 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
An interesting report by Streetz et al. published in HEPATOLOGY described the production of hepatocyte conditional gp130 knockout mice subjected to chronic liver injury by repeated carbon tetrachloride (CCl 4 ) treatment. 1 Chronic injury induces liver regeneration by recruitment of cells from a pre
End-stage liver disease secondary to hepatitis C virus (HCV) infection is the leading indication for liver transplantation in the United States. Recurrence of HCV infection is nearly universal. We studied the patients enrolled in the National Institute of Diabetes and Digestive and Kidney Diseases L
The aim of this study was to evaluate the rate of alcohol recidivism after orthotopic liver transplantation (OLT) for alcoholic liver disease (ALD) and its influence on the allograft and patient survival, as well as the development of comorbidities and de novo cancers. The study was performed on 54
## AND SOLKO W. SCHALM~ We studied the size of the liver graft and the host liver in six consecutive patients undergoing auxiliary heterotopic liver transplantation for chronic endstage liver disease. In all cases, a liver reduced in size by left lateral hepatectomy was inserted. The sizes of the
The benefit of liver transplantation (LT) is determined not only by the severity of illness, but also by the likelihood of posttransplantation survival. Current models are unable to accurately predict which patients will have the best posttransplant survival. We hypothesized that the Charlson Comorb